Paradigm Capital Management Inc. NY Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Paradigm Capital Management Inc. NY grew its holdings in Codexis, Inc. (NASDAQ:CDXS – Free Report) by 66.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 500,000 shares of the biotechnology company’s stock after buying an additional 200,000 shares during the quarter. Paradigm […]
The demand for diagnostic specialty enzymes will be driven by point-of-care diagnostics and infectious disease diagnostics.Wilmington, Delaware, United States, Feb. 16, 2024 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The diagnostic specialty enzymes industry was worth US$ 1.0 billion in 2022. A CAGR of 6.9% is predicted from 2023 to 2031, leading to a market size of US$ 1.8 billion in 2031. The diagnostic specialized enzymes market is projected to experience continual technical brea
Codexis Secures $40 Million In Strategic Financing Deal With Innovatus Capital Partners To Further Strengthen Cash Position Ahead Of Key Milestones menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.